While ZIKV has been shown to elicit an anti-IFN response during infection, specific IFNs and ISGs have demonstrated the ability to decrease ZIKV infection in human cervical cancer cells, lung epithelial cells, and placental trophoblasts [18, 19]. This evidence concerns the gene IFNA1 and infection.